Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk
Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk. C González-Yanes and V Sánchez-Margalet Department of Medical Biochemistry and Molecular Biology, School of Medicine, Virgen Macarena University Hospital, University of Seville, Spain. Abstract Pancreastatin (PST)...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2000-08, Vol.49 (8), p.1288-1294 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk.
C González-Yanes and
V Sánchez-Margalet
Department of Medical Biochemistry and Molecular Biology, School of Medicine, Virgen Macarena University Hospital, University
of Seville, Spain.
Abstract
Pancreastatin (PST), a chromogranin A-derived peptide, has counterregulatory effects on insulin in the hepatocyte and the
adipocyte, suggesting a possible role in insulin resistance. The mechanism of PST action on glucose and lipid metabolism is
typical of a calcium-mobilizing hormone and involves a receptor Gq/11 protein-phospholipase C (PLC)-beta pathway. In the rat
adipocyte, PST inhibits insulin-mediated glucose transport, glucose utilization, and lipid synthesis, and it has a lipolytic
effect but stimulates basal and insulin-stimulated protein synthesis. We have also recently studied the PST receptor-effector
system in adipocyte membranes. To further investigate the mechanisms of PST effect on insulin action, we studied the cross-talk
of PST with insulin signaling in the rat adipocyte. We found that PST inhibits insulin-stimulated GLUT4 translocation to the
membrane, which may explain the reported inhibition of glucose transport. Tyrosine phosphorylation of the activated insulin
receptor, insulin receptor substrate (IRS)-1, and p60-70 was also blunted, preventing their association with p85 phosphatidylinositol
3-kinase (PI3K) and their activity. The mechanism of this inhibition involves the activation of the "classical" protein kinase
C isoforms and the serine phosphorylation of insulin receptor and IRS-1. On the other hand, PST activates the mitogen-activated
protein kinase (MAPK) signaling module and enhances the effect of insulin. This pathway may account for the described effect
of PST on protein synthesis. In conclusion, PST seems to inhibit the insulin-stimulated PI3K pathway in the adipocyte, whereas
it activates the MAPK pathway. These data provide some clues to the PST cross-talk with insulin signaling that may explain
the PST effects on glucose metabolism and protein synthesis. |
---|---|
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.49.8.1288 |